TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: AUC for Magnesium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment intervention related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Treatment intervention related serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Visual numeric pain scale (VNS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: remission of clinical disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Long-term quality of life (mental component)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Salivary acid and base value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time taken to control GERD symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mean objective assessment of blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Functional Anterior Temporal Lobe activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Successful ventricular pacing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ventricular pacing threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: buccal Recession (bREC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skin redness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Facial skin pores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Facial skin texture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Feasibility assessed by study recruitment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Feasibility assessed by outcome assessment completion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Feasibility assessed by adherence to the intervention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Acceptability as assessed by a NMES-specific questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: RSV Lower Respiratory Tract Disease Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in predictive capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in reward-related brain responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in reward related behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in eating behaviour
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Soft tissue texture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mucogingival junction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gingival color
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of days participants log in to the app
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Total time participants spend using the app
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of days participants log medications using the app
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: CAVI measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Plasma Concentration of Risdiplam
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in CAPS-5 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline perceived sleep quality
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Proportion of enteral nutrition starting within 48 hours after ICU entry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nutritional outcomes
Primary endpoint: Short Opioid Withdrawal Scale Gossop (SOWS-Gossop)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Opioid Withdrawal Scale (COWS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Opioid Craving Visual Analog Scale (OC-VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Time [Tmax]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax for FRSW117
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax for ADVATE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Episodes of resident agitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in PTSD symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in adult depression and anxiety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in youth depression and anxiety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of hybrid closed-loop systems
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Knowledge Test Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Standardized uptake value of 11C-Choline in LAM lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Vascular access survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Burnout prevalence and intensity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of time spent in range 70-180 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: fMRI brain activation in response to stress during a taste reward task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: fMRI brain activation in response to stress during a body size estimation task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in molecular profile of urothelial cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety profile of PLB1004
Endpoint domain: Adverse events/effects
Primary endpoint: Intensity of acute post-surgical pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of Persistent post-surgical pain, 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Persistent post-surgical pain, 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Combined Incidence of HPV-related cancers
Endpoint domain: Mortality/survival
Primary endpoint: Number of Participants With Treatment-emergent Adverse Events, by Severity
Endpoint domain: Adverse events/effects
Primary endpoint: Vascularity in axillary lymph nodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Distribution of vessels in axillary lymph nodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Appearance of vessels in axillary lymph nodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percent tapered off of opioid (opioid naive)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent tapered off of opioid (opioid tolerant)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pulse oximetry Accuracy - Root Mean Square
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bladder-intact Disease-free Survival (BI-DFS)
Endpoint domain: Mortality/survival
Primary endpoint: Amount of muscle sympathetic nerve activity (MSNA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Major molecular remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change of muscle force in Nm of the plantar flexors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Cerebral blood flow change rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Adherence to Physiotherapy Scoliosis Specific Exercises
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Incremental area under the curve (iAUC) 180 Glucose Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: TrkB/C receptor binding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TrkB/C concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: prevalence and type of sleeping disorders
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: presence and degree of anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: presence and degree of depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of Adverse events after C-4-29 infusion
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum tolerated dose of C-4-29 cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of occult HCV infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in histopathology of abdominoplasty tissue samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: tracheal tube-related tongue injury
Endpoint domain: Adverse events/effects
Primary endpoint: Diagnostic sensitivity and specificity of FIT-DNA detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Patient reported Quality of Life 1
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Patient reported Quality of Life 2
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: freedom from atrial fibrillation (AF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Average number of voiding episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Average number of urgency episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Average number of urgency-incontinence episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Viscoelastic properties
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Microbiota awareness scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Chromatic values of the upper central incisors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of patients achieving target heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of Participants with Meaningful Hair Loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Time to Onset of Hair Loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of Participants with Improvement in Hair Loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Level of baseline PSQ
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of baseline PSQ after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in inflammatory nodule/abscess count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Percent Change in Blood Phenylalanine Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Over jet reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of immune-related AEs (irAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Clutter Image Rating Scale (CIR)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Frequency of intracranial hemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: rate of adverse placental outcomes
Endpoint domain: Adverse events/effects
Primary endpoint: Change from Baseline in the modified Mayo Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Percentage of Heavy Drinking Days Per Month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Remission from DSM-5 AUD Diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Biopsychosocial Functioning
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Absence of Hematoma Formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measure and Categorize Amount of Blood Loss From Biopsy Access Site
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Absence of the Need for Ultrasound Examination Due to Observation of Bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gram-negative bloodstream infection
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline in total fatigue score as assessed by the Fatigue Impact Scale (MFIS)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Postoperative Visual Analog Scale (VAS) values
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Change in the IBS severity symptom score (IBS-SSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: duration of nighttime sleep in hours
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: sleep problems as frequent awakening during the night
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Cardiac arrhythmia from side effects of methadone
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Perceived Stress Scale (PSS) scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Dentoskeletal changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain Now
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Worst Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Least Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Delta of the WAS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: the number of patients with adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: the number of patients with clinically significant change from baseline in vital signs value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: the number of patients with clinically significant change in physical examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage change from baseline in EASI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: change in biotinidase level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Children's knowledge related to nephrotic syndrome
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Children's self-reported health-related practices
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Caregivers' knowledge related to nephrotic syndrome
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Caregivers' self-reported health-related practices
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pediatric Symptom Checklist-17 (Psc-17)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Renal FAP expression level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in peri-implant marginal bone level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Primary Adverse Events (PAE)
Endpoint domain: Adverse events/effects
Primary endpoint: symptomatic hypocalcaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Average End-of-year Adherence Level
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Absence or reduction of IRF at Month 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absence or reduction of SRF at Month 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absence or reduction of PED at Month 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quebec User Evaluation of Satisfaction with Assistive Technology questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Antibacterial Effect in Active Dental Caries Lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antibacterial Activity and Caries Activity in Dental Caries Lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antibacterial Effect in Unstimulated Saliva Samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-year local control rate
Endpoint domain: Mortality/survival
Primary endpoint: Clinically important difference in PROMIS-29 T score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinically important difference in PROMIS mental health summary score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Olfactory perceptual decision-making performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pulmonary bacteriologically confirmed TB notifications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Safety of fractional dose intradermal administration
Endpoint domain: Adverse events/effects
Primary endpoint: Immunogenicity of fractional dose intradermal administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Safety of full dose intramuscular administration
Endpoint domain: Adverse events/effects
Primary endpoint: Immunogenicity of full dose intramuscular administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Attack Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-Traumatic Stress Disorder Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Subacromial space dimensions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Technology Feasibility Scale Rating
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Self-Efficacy Scale Rating
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Stress Reduction Scale Rating
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in intestinal microbiome signature
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Hematological complete response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Organ response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients who use the sleep improvement intervention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Level of satisfaction with the intervention as assessed by a Likert assessment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of liver tumors identified
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Contrast of neoplastic vs non-neoplastic Barrett's
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: visual information processing function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reversal of Oligohydramnios
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Rate of patients having their clinical data registered
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of patients for whom information on biological samples/material is collected
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Higher order aberration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Death at 28 days after cardiogenic shock
Endpoint domain: Mortality/survival
Primary endpoint: Skeletal muscle protein fractional synthesis rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants achieving at least 5% body weight reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: RPE morphology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes